Meet our corporate governance

François Blondel

CEO, Managing Director

Learn more
François Blondel – CEO, Managing Director Having graduated in both Law and Science Economics (UCLouvain), he nowadays combines his executive functions (as CEO of KitoZyme and Executive Chairman of KiOmed Pharma and BiOkuris) with non-executive board memberships, either as Chairman of the Board or as an independent board member.

The companies in which he either is active or was up until recently active range from SMEs and spin-offs, such as OncoDNA, NANOCYL and Delphi GENETICS, which are active in the technology, medical or healthcare sectors to major listed companies, including RECTICEL or Compagnie du BOIS SAUVAGE and public authorities, such as AWEX, AMONIS or BioWIN.

As an entrepreneur, he has (co)founded several start-ups and gained broad experience in the management of innovation–driven companies. He began his career in the chemical sector with assignments both in the United States and in Europe. In 1999, he joined International Brachytherapy, an oncology medical device start-up. He served as CEO, leading IBt, an NYSE-Euronext stock listed company, from its R&D stage to a successful and well-diversified international group that became a European leader in its market segment.

Hide François Blondel's information

Gery Lefebvre

Investment Manager at Wallonie Entreprendre (WE)

Learn more
Gery Lefebvre – Investment Manager at Wallonie Entreprendre (WE) Mr Gery Lefebvre holds several non-executive mandates in biotech start-ups/spin-offs and companies that are active in the life sciences and industrial sectors.

In 1995, Gery Lefebvre graduated in Business Administration from HEC-ULg and immediately started his career in Credit Management with Atradius and later in Corporate Banking at HSBC in Paris. In 2002, he obtained a post-graduate Master in Taxation from HEC-ULg. Following this, he moved to Albemarle Europe where he was responsible for Treasury Management and Working Capital Optimization. From 2009 – 2014, he was the CFO of Belgian Advanced Technology Systems SA

Hide Gery Lefebvre 's information

Pascal Lizin

Pascal Lizin – Board member

Learn more
Chairman or member of the Board of several Biotech companies - strategic advisor to Investment Funds (Belgium). Mr Pascal Lizin has a long career in the private sector, and more specifically for agro-food, biotechnology companies and professional federations, before joining different public institutions.

As Chairman of the Board of the federal investment company, he contributed recently to anchor and invest in strategic assets and sectors in the country to the benefit of the economy and to the citizen. He also been appointed as expert to several Belgian governmental steering groups on industrialization, innovation, exportation and Brexit. Working closely with Universities and high schools, he’s also involved in different academic initiatives.

Hide Pascal Lizin's information

Benoît Fellin

Managing Partner - Spinventure (Noshaq)

Learn more
Mr. Fellin specializes in Biotech companies

Mr. Fellin specializes in Biotech companies, spin-offs and SMEs that are active in the healthcare and industrial sectors.

Hide Benoît Fellin's information
Meet our scientific advisors